Key result
In acute PE, eGFR predicts ~124% greater 30-day mortality, refining sPESI while other markers fail.
Why the study?
Certain laboratory and echocardiographic parameters not included in sPESI might indicate worse outcomes in pulmonary embolism, prompting evaluation of whether adding BNP, TnI, echocardiography, or GFR improves prognostic value.
Does incorporating estimated glomerular filtration rate (eGFR) into the simplified pulmonary embolism severity index (sPESI) improve mortality risk prediction in patients with acute pulmonary embolism?
Cohort (n=1,201)
Does incorporating estimated glomerular filtration rate (eGFR) into the simplified pulmonary embolism severity index (sPESI) improve mortality risk prediction in patients with acute pulmonary embolism?
Hazard Ratio: 2.24 (95% CI 1.264–3.969)
p-value: p=0.006
Renal dysfunction at admission is a strong, independent predictor of 30-day mortality in acute pulmonary embolism, and its integration with a three-level sPESI score optimizes prognostic stratification.
eGFR may refine sPESI risk stratification in acute PE; hypothesis-generating pending prospective validation.
Background/Aim Patients classified as belonging to simplified pulmonary embolism severity index (sPESI) class 0 are considered to have low-risk pulmonary embolism (PE). Yet, certain laboratory and echocardiographic parameters not accounted for in the sPESI score might suggest a likelihood of worse outcomes in PE cases. This study seeks to determine if the prognostic value of the sPESI score in acute PE can be improved, refined, and optimised by incorporating brain natriuretic peptide (BNP) and troponin I (TnI) levels, echocardiographic parameters, or glomerular filtration rate. Methods The study encompassed 1,201 consecutive patients diagnosed with PE, confirmed by - multidetector computed tomography (MDCT). Upon admission, each patient underwent an echocardiography exam, and blood samples were taken to measure B-type natriuretic peptide (BNP), troponin I (TnI), creatinine, and other routine laboratory markers. Results The in-hospital mortality rate was 11.5%. The patients were categorized into three groups using the three-level sPESI model: sPESI 0, sPESI 1, and sPESI ≥ 2. Statistically significant differences were found among these groups regarding mortality rates, TnI values, BNP levels, estimated glomerular filtration rate (eGFR), and the presence of right ventricular dysfunction (RVD). Cox regression analysis identified eGFR as the most reliable predictor of 30-day all-cause mortality [HR 2.24 (CI 1.264-3.969); p=0.006] across all sPESI categories. However, incorporating TnI, BNP, or RVD did not improve risk prediction beyond the three-level sPESI model. Conclusion Renal dysfunction at the time of admission is closely related to an elevated risk of in-hospital mortality in patients with acute PE. The three-level sPESI score offers a more accurate method for prognostic stratification in these patients.
No takes yet. Share an insight, caveat, or question.
Salinger et al. (2025) conducted a cohort in acute pulmonary embolism (n=1,201). Estimated glomerular filtration rate (eGFR) was evaluated on 30-day all-cause mortality (HR 2.24, 95% CI 1.264-3.969, p=0.006). Estimated glomerular filtration rate was the most reliable predictor of 30-day all-cause mortality in acute pulmonary embolism across all sPESI categories (HR 2.24; 95% CI 1.264-3.969; p=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: